Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
  1. 4 Shares withheld for taxes Chief Operating Officer gave up 2,133 shares (to pay taxes)
  2. 5 Insider Annual Insider Trading Report
  3. 5 Insider Annual Insider Trading Report
  4. 5 Insider Annual Insider Trading Report
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 7,033 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Operating Officer gave up 3,117 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Pres., Novocure Oncology gave up 966 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Human Resources Officer gave up 752 shares (to pay taxes)
  9. 4 Open-market buy Chief Executive Officer bought 81,550 shares at $12.22 ($996,859)
  10. 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $11.59 ($231,800)
  11. 4 Grant or award Chief Human Resources Officer acquired 833 shares (grant or award)
  12. 4 Grant or award EVP, Pres., Novocure Oncology acquired 833 shares (grant or award)
  13. 4 Grant or award Director acquired 833 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 833 shares (grant or award)
  15. 4 Grant or award General Counsel acquired 769 shares (grant or award)
  16. 4 Grant or award Director acquired 11,215 shares (grant or award)
  17. 4 Grant or award Director acquired 11,215 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 11,215 shares (grant or award)
  20. 4 Grant or award Director acquired 11,215 shares (grant or award)

Page 3 of 39 · 780 filings